Search / Trial NCT06232486

Relationship Between Serum Vitamin D Levels and Postherpetic Neuralgia.

Launched by FENG GAO · Jan 22, 2024

Trial Information

Current as of October 07, 2024

Unknown status

Keywords

Herpes Zoster,Post Herpes Zoster,Vitamin D,

Description

Herpes zoster is a neuropathic disease which induce by the varicella-herpes virus reactivation.and postherpetic neuralgia (PHN) is the most common complication. Currently,the mechanism of herpes zoster still unclearly even though there had much study about it .Vitamin D is an essential vitamin for human body, which has the function of maintaining calcium and phosphorus homeostasis and immune regulation. Vitamin D is a natural antiviral substance, and vitamin D deficiency can affect the body's antiviral ability, thereby promoting varicella-zoster virus(VZV) reactivation, and may promote the ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Age ≥18 years.
  • * The patient was diagnosed with herpetic neuralgia and the course of disease was ≤3 months.
  • * Can cooperate with the completion of inquiry and scale evaluation.
  • Exclusion Criteria:
  • * Severe spinal disease (fracture, malignancy, acute or chronic infection) confirmed by previous spinal surgery or imaging.
  • * Previous history of head trauma.
  • * Have autoimmune diseases (systemic lupus erythematosus, rheumatoid arthritis, leucothrombocytopenia).
  • * Suffering from mental disorders, intellectual disability, epilepsy and other diseases.
  • * A history of substance abuse, drug abuse or alcohol abuse.
  • * Pregnant or breastfeeding women.
  • * And recent participation in other clinical studies.

About Feng Gao

Feng Gao is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on rigorous scientific methodologies and ethical standards, Feng Gao collaborates with healthcare professionals and research institutions to facilitate the development and testing of novel treatments across various medical fields. By prioritizing patient safety and data integrity, the organization aims to contribute significantly to the advancement of healthcare and the discovery of effective interventions for unmet medical needs.

Locations

Wuhan, Hubei, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0